Anna Maria Tokes
Overview
Explore the profile of Anna Maria Tokes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kovacs K, Kerepesi C, Rapcsak D, Madaras L, Nagy A, Takacs A, et al.
Sci Rep
. 2025 Feb;
15(1):4868.
PMID: 39929942
Local recurrences (LR) can occur within residual breast tissue, chest wall, skin, or newly formed scar tissue. Artificial intelligence (AI) technologies can extract a wide range of tumor features from...
2.
Andour L, Hagenaars S, Gregus B, Tokes A, Karancsi Z, Tollenaar R, et al.
Virchows Arch
. 2025 Feb;
PMID: 39904885
Previous literature extensively explored biomarkers to personalize treatment for breast cancer patients. The clinical need is especially high in patients with triple-negative breast cancer (TNBC) due to its aggressive nature...
3.
Karancsi Z, Gregus B, Krenacs T, Cserni G, Nagy A, Szocs-Trinfa K, et al.
Int J Mol Sci
. 2024 Sep;
25(17).
PMID: 39273393
Triple-negative breast cancer (TNBC) is a subtype of breast cancer with a poor prognosis and limited treatment options. This study evaluates the prognostic value of stromal markers in TNBC, focusing...
4.
Pipek O, Alpar D, Rusz O, Bodor C, Udvarnoki Z, Medgyes-Horvath A, et al.
Int J Mol Sci
. 2023 May;
24(10).
PMID: 37239898
A limited number of studies have focused on the mutational landscape of breast cancer in different ethnic populations within Europe and compared the data with other ethnic groups and databases....
5.
Karancsi Z, Hagenaars S, Nemeth K, Mesker W, Tokes A, Kulka J
Virchows Arch
. 2023 May;
485(4):703-716.
PMID: 37198327
Purpose: Tumour-stroma ratio (TSR) is an important prognostic and predictive factor in several tumour types. The aim of this study is to determine whether TSR evaluated in breast cancer core...
6.
Barcsay-Veres A, Tokes A, Toth J, Szilagyi Z, Toth E, Nagy Z, et al.
Case Rep Oncol
. 2022 Jun;
15(2):486-493.
PMID: 35702674
The aim of the study was to report a case of severe meibomian gland dysfunction (MGD) and conjunctival changes associated with trastuzumab, pertuzumab, and anastrozole therapy in a HER-2 positive...
7.
Szeitz B, Pipek O, Kulka J, Szundi C, Rusz O, Tokes T, et al.
Cancers (Basel)
. 2022 Apr;
14(8).
PMID: 35454849
We hypothesized that different BC subtypes are characterized by spatially distinct tumor immune microenvironment (TIME) and that immune gene assembly of metastatic (Met) and non-metastatic (Ctrl) BCs vary across subtypes....
8.
Tokes A, Vari-Kakas S, Kulka J, Torocsik B
Front Oncol
. 2022 Apr;
12:850401.
PMID: 35433453
Breast cancer is characterized by considerable metabolic diversity. A relatively high percentage of patients diagnosed with breast carcinoma do not respond to standard-of-care treatment, and alteration in metabolic pathways nowadays...
9.
Madaras L, Baranyak Z, Kulka J, Szasz A, Kovacs A, Huong Lan P, et al.
Pathol Oncol Res
. 2013 May;
19(4):723-9.
PMID: 23709114
Patients at young age (≤ 35 years) diagnosed with breast cancer (BC) are considered to have poor prognosis. The aim of the present study was to retrospectively analyse clinicopathological characteristics...